NASDAQ:ITRM Investor Notice: Lawsuit Alleges Securities Laws Violations by Iterum Therapeutics Plc
An investor, who purchased NASDAQ:ITRM shares, filed a lawsuit against Iterum Therapeutics plc over alleged Securities Laws violations.
View full press release